ArticleJournal of molecular medicine (Berlin, Germany)2013

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.

Krishan Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.